Article
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
Journal of neuroimmunology - 1 Jun 2005
Leyva Laura, Fernández Oscar, Fedetz Maria, Blanco Eva, Fernández Victoria E, Oliver Begoña, León Antonio, Pinto-Medel Maria-Jesus, Mayorga Cristobalina, Guerrero Miguel, Luque Gloria, Alcina Antonio, Matesanz Fuencisla
Abstract excerpt
We investigated the role of three polymorphisms in the IFNAR1 (SNPs 18417 and -408) and IFNAR2 (SNP 11876) genes in multiple sclerosis (MS) susceptibility and in the IFNbeta treatment response in a group of 147 patients and 210 controls undergoing interferon therapy during the last 2 years. Only the 18417 and the 11876 SNPs showed an association with disease susceptibility (p=0.001 and 0.035, respectively)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
